Literature DB >> 28096089

Tolerogenic interactions between CD8+ dendritic cells and NKT cells prevent rejection of bone marrow and organ grafts.

David Hongo1, Xiaobin Tang1, Xiangyue Zhang2, Edgar G Engleman1,2, Samuel Strober1.   

Abstract

The combination of total lymphoid irradiation and anti-T-cell antibodies safely induces immune tolerance to combined hematopoietic cell and organ allografts in humans. Our mouse model required host natural killer T (NKT) cells to induce tolerance. Because NKT cells normally depend on signals from CD8+ dendritic cells (DCs) for their activation, we used the mouse model to test the hypothesis that, after lymphoid irradiation, host CD8+ DCs play a requisite role in tolerance induction through interactions with NKT cells. Selective deficiency of either CD8+ DCs or NKT cells abrogated chimerism and organ graft acceptance. After radiation, the CD8+ DCs increased expression of surface molecules required for NKT and apoptotic cell interactions and developed suppressive immune functions, including production of indoleamine 2,3-deoxygenase. Injection of naive mice with apoptotic spleen cells generated by irradiation led to DC changes similar to those induced by lymphoid radiation, suggesting that apoptotic body ingestion by CD8+ DCs initiates tolerance induction. Tolerogenic CD8+ DCs induced the development of tolerogenic NKT cells with a marked T helper 2 cell bias that, in turn, regulated the differentiation of the DCs and suppressed rejection of the transplants. Thus, reciprocal interactions between CD8+ DCs and invariant NKT cells are required for tolerance induction in this system that was translated into a successful clinical protocol.
© 2017 by The American Society of Hematology.

Entities:  

Mesh:

Year:  2017        PMID: 28096089      PMCID: PMC5364338          DOI: 10.1182/blood-2016-07-723015

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  45 in total

Review 1.  NKT cells, Treg, and their interactions in bone marrow transplantation.

Authors:  Holbrook E Kohrt; Asha B Pillai; Robert Lowsky; Samuel Strober
Journal:  Eur J Immunol       Date:  2010-07       Impact factor: 5.532

Review 2.  NKG2D Receptor and Its Ligands in Host Defense.

Authors:  Lewis L Lanier
Journal:  Cancer Immunol Res       Date:  2015-06       Impact factor: 11.151

3.  Protective conditioning for acute graft-versus-host disease.

Authors:  Robert Lowsky; Tsuyoshi Takahashi; Yin Ping Liu; Sussan Dejbakhsh-Jones; F Carl Grumet; Judith A Shizuru; Ginna G Laport; Keith E Stockerl-Goldstein; Laura J Johnston; Richard T Hoppe; Daniel A Bloch; Karl G Blume; Robert S Negrin; Samuel Strober
Journal:  N Engl J Med       Date:  2005-09-29       Impact factor: 91.245

4.  Regulation of T cell activation and tolerance by PDL2.

Authors:  Yongliang Zhang; Yeonseok Chung; Caroline Bishop; Betsy Daugherty; Hilary Chute; Paige Holst; Carole Kurahara; Fred Lott; Ning Sun; Andrew A Welcher; Chen Dong
Journal:  Proc Natl Acad Sci U S A       Date:  2006-07-24       Impact factor: 11.205

5.  CD8+ CD205+ splenic dendritic cells are specialized to induce Foxp3+ regulatory T cells.

Authors:  Sayuri Yamazaki; Diana Dudziak; Gordon F Heidkamp; Christopher Fiorese; Anthony J Bonito; Kayo Inaba; Michel C Nussenzweig; Ralph M Steinman
Journal:  J Immunol       Date:  2008-11-15       Impact factor: 5.422

Review 6.  IDO expression by dendritic cells: tolerance and tryptophan catabolism.

Authors:  Andrew L Mellor; David H Munn
Journal:  Nat Rev Immunol       Date:  2004-10       Impact factor: 53.106

7.  Tolerance and chimerism after renal and hematopoietic-cell transplantation.

Authors:  John D Scandling; Stephan Busque; Sussan Dejbakhsh-Jones; Claudia Benike; Maria T Millan; Judith A Shizuru; Richard T Hoppe; Robert Lowsky; Edgar G Engleman; Samuel Strober
Journal:  N Engl J Med       Date:  2008-01-24       Impact factor: 91.245

8.  A new triggering receptor expressed on myeloid cells (Trem) family member, Trem-like 4, binds to dead cells and is a DNAX activation protein 12-linked marker for subsets of mouse macrophages and dendritic cells.

Authors:  Hiroaki Hemmi; Juliana Idoyaga; Koji Suda; Nao Suda; Kathleen Kennedy; Masaki Noda; Alan Aderem; Ralph M Steinman
Journal:  J Immunol       Date:  2009-02-01       Impact factor: 5.422

9.  The induction of tolerance by dendritic cells that have captured apoptotic cells.

Authors:  R M Steinman; S Turley; I Mellman; K Inaba
Journal:  J Exp Med       Date:  2000-02-07       Impact factor: 14.307

10.  A single subset of dendritic cells controls the cytokine bias of natural killer T cell responses to diverse glycolipid antigens.

Authors:  Pooja Arora; Andres Baena; Karl O A Yu; Neeraj K Saini; Shalu S Kharkwal; Michael F Goldberg; Shajo Kunnath-Velayudhan; Leandro J Carreño; Manjunatha M Venkataswamy; John Kim; Eszter Lazar-Molnar; Gregoire Lauvau; Young-tae Chang; Zheng Liu; Robert Bittman; Aymen Al-Shamkhani; Liam R Cox; Peter J Jervis; Natacha Veerapen; Gurdyal S Besra; Steven A Porcelli
Journal:  Immunity       Date:  2014-01-09       Impact factor: 31.745

View more
  14 in total

Review 1.  Natural and Induced Tolerogenic Dendritic Cells.

Authors:  Courtney A Iberg; Daniel Hawiger
Journal:  J Immunol       Date:  2020-02-15       Impact factor: 5.422

2.  Mixed chimerism and acceptance of kidney transplants after immunosuppressive drug withdrawal.

Authors:  Stephan Busque; John D Scandling; Robert Lowsky; Judith Shizuru; Kent Jensen; Jeffrey Waters; Hsin-Hsu Wu; Kevin Sheehan; Asha Shori; Okmi Choi; Thomas Pham; Marcelo A Fernandez Vina; Richard Hoppe; John Tamaresis; Philip Lavori; Edgar G Engleman; Everett Meyer; Samuel Strober
Journal:  Sci Transl Med       Date:  2020-01-29       Impact factor: 17.956

Review 3.  Unconventional T cells and kidney disease.

Authors:  Hannah Kaminski; Lionel Couzi; Matthias Eberl
Journal:  Nat Rev Nephrol       Date:  2021-08-26       Impact factor: 28.314

4.  Development of immunosuppressive myeloid cells to induce tolerance in solid organ and hematopoietic cell transplant recipients.

Authors:  Kent P Jensen; David A Hongo; XuHuai Ji; PingPing Zheng; Rahul Pawar; Thomas Hsin-Hsu Wu; Stephan Busque; John D Scandling; Judith A Shizuru; Robert Lowsky; Asha Shori; Suparna Dutt; Jeffrey Waters; Anirudh Saraswathula; Jeanette Baker; John S Tamaresis; Philip Lavori; Robert Negrin; Holden Maecker; Edgar G Engleman; Everett Meyer; Samuel Strober
Journal:  Blood Adv       Date:  2021-09-14

Review 5.  Macrochimerism and clinical transplant tolerance.

Authors:  John D Scandling; Stephan Busque; Robert Lowsky; Judith Shizuru; Asha Shori; Edgar Engleman; Kent Jensen; Samuel Strober
Journal:  Hum Immunol       Date:  2018-01-09       Impact factor: 2.850

Review 6.  Tissue-specific functions of invariant natural killer T cells.

Authors:  Catherine M Crosby; Mitchell Kronenberg
Journal:  Nat Rev Immunol       Date:  2018-09       Impact factor: 53.106

Review 7.  Transplantation Tolerance through Hematopoietic Chimerism: Progress and Challenges for Clinical Translation.

Authors:  Benedikt Mahr; Nicolas Granofszky; Moritz Muckenhuber; Thomas Wekerle
Journal:  Front Immunol       Date:  2017-12-22       Impact factor: 7.561

Review 8.  Invariant Natural Killer T Cells As Suppressors of Graft-versus-Host Disease in Allogeneic Hematopoietic Stem Cell Transplantation.

Authors:  Melissa Mavers; Kristina Maas-Bauer; Robert S Negrin
Journal:  Front Immunol       Date:  2017-07-31       Impact factor: 7.561

9.  The Long Noncoding RNA MALAT1 Induces Tolerogenic Dendritic Cells and Regulatory T Cells via miR155/Dendritic Cell-Specific Intercellular Adhesion Molecule-3 Grabbing Nonintegrin/IL10 Axis.

Authors:  Jian Wu; Hanlu Zhang; Yang Zheng; Xiangyuan Jin; Mingyang Liu; Shuang Li; Qi Zhao; Xianglan Liu; Yongshun Wang; Ming Shi; Shengnan Zhang; Jinwei Tian; Yong Sun; Maomao Zhang; Bo Yu
Journal:  Front Immunol       Date:  2018-08-13       Impact factor: 7.561

10.  Innate Immune Determinants of Graft-Versus-Host Disease and Bidirectional Immune Tolerance in Allogeneic Transplantation.

Authors:  Anouk A J Hamers; Sunil K Joshi; Asha B Pillai
Journal:  OBM Transplant       Date:  2019-01-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.